Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. For example, the present invention provides methods of treating immune and/or inflammatory disorders by administering a composition comprising a compound having the structure of Formula (I).
Type:
Grant
Filed:
October 21, 2022
Date of Patent:
December 19, 2023
Assignees:
California Institute of Technology, Holoclara, Inc.
Inventors:
Brian M. Stoltz, Corey M. Reeves, Eduardo J. Martinez, Simon Bailey